These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 26240227)

  • 41. Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia.
    Lee JH; Lee JH; Kim DY; Yun SC; Kim SD; Choi Y; Lee YS; Kang YA; Jeon MJ; Seol M; Lee KH
    Eur J Haematol; 2011 Aug; 87(2):172-81. PubMed ID: 21599753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.
    Itonaga H; Taguchi J; Fukushima T; Tsushima H; Sato S; Ando K; Sawayama Y; Matsuo E; Yamasaki R; Onimaru Y; Imanishi D; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Honda S; Miyazaki Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):607-15. PubMed ID: 23333533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.
    Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N;
    Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT.
    Giebel S; Labopin M; Ibatici A; Browne P; Czerw T; Socie G; Unal A; Kyrcz-Krzemien S; Bacigalupo A; Goker H; Potter M; Furness CL; McQuaker G; Beelen D; Milpied N; Campos A; Craddock C; Nagler A; Mohty M
    Oncologist; 2016 Mar; 21(3):377-83. PubMed ID: 26869584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Rubio MT; Labopin M; Blaise D; Socié G; Contreras RR; Chevallier P; Sanz MA; Vigouroux S; Huynh A; Shimoni A; Bulabois CE; Caminos N; López-Corral L; Nagler A; Mohty M
    Haematologica; 2015 May; 100(5):683-9. PubMed ID: 25769546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis.
    Yanada M; Matsuo K; Suzuki T; Naoe T
    Cancer; 2006 Jun; 106(12):2657-63. PubMed ID: 16703597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial.
    Pfirrmann M; Ehninger G; Thiede C; Bornhäuser M; Kramer M; Röllig C; Hasford J; Schaich M;
    Lancet Oncol; 2012 Feb; 13(2):207-14. PubMed ID: 22197676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
    Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Szer J
    Intern Med J; 2005 Jan; 35(1):18-27. PubMed ID: 15667464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The outcome of allogeneic hematopoietic stem cell transplants without total body irradiation in pediatric patients with acute lymphoblastic leukemia: single centre experience.
    Hamidieh A; Kargar M; Jahani M; Alimoghaddam K; Bahar B; Mousavi SA; Iravani M; Jalali A; Jalili M; Ghavamzadeh A
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):101-7. PubMed ID: 22367385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
    Schmid C; Labopin M; Nagler A; Bornhäuser M; Finke J; Fassas A; Volin L; Gürman G; Maertens J; Bordigoni P; Holler E; Ehninger G; Polge E; Gorin NC; Kolb HJ; Rocha V;
    J Clin Oncol; 2007 Nov; 25(31):4938-45. PubMed ID: 17909197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
    Gratwohl A; Stern M; Brand R; Apperley J; Baldomero H; de Witte T; Dini G; Rocha V; Passweg J; Sureda A; Tichelli A; Niederwieser D;
    Cancer; 2009 Oct; 115(20):4715-26. PubMed ID: 19642176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Frassoni F; Sanz G; Demeocq F; Prentice H; Cahn JY; Barbui T; Meloni G; Schaefer U; Reiffers J; Gorin N
    Bone Marrow Transplant; 1999 Aug; 24(4):389-96. PubMed ID: 10467328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EuroSCORE vs. EuroSCORE II vs. Society of Thoracic Surgeons risk algorithm.
    Qadir I; Alamzaib SM; Ahmad M; Perveen S; Sharif H
    Asian Cardiovasc Thorac Ann; 2014 Feb; 22(2):165-71. PubMed ID: 24585787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia.
    Al-Shaibani E; Cyriac S; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law A; Al-Shaibani Z; Gerbitz A; Pasic I; Mattsson J; Michelis FV
    Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e559-e568. PubMed ID: 33678592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome predictors of allogeneic hematopoietic stem cell transplant.
    Yang WC; Chen YT; Chang WW; Chang CH; Fan PC; Lee SY; Kao KC; Tian YC; Hung CC; Fang JT; Yang CW; Chen YC; Wang PN
    Am J Med Sci; 2013 Jan; 345(1):33-8. PubMed ID: 22475735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Nutritional Parameters with Clinical Outcomes in Patients with Acute Myeloid Leukemia Undergoing Haematopoietic Stem Cell Transplantation.
    Baumgartner A; Zueger N; Bargetzi A; Medinger M; Passweg JR; Stanga Z; Mueller B; Bargetzi M; Schuetz P
    Ann Nutr Metab; 2016; 69(2):89-98. PubMed ID: 27639391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.
    Bari R; Rujkijyanont P; Sullivan E; Kang G; Turner V; Gan K; Leung W
    J Clin Oncol; 2013 Oct; 31(30):3782-90. PubMed ID: 24043749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.